JPRN-UMIN000013325尚未招募2 期
WT1 peptide-based cancer vaccine in patients with high risk rhabdomyosarcoma, a multicenter, phase 2 clinical study - WT1 peptide-based cancer vaccine in patients with high risk rhabdomyosarcoma, a multicenter, phase 2 clinical study
Osaka university graduate school of medicine Pediatrics0 个研究点目标入组 33 人开始时间: 2014年3月4日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 30years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Active bacterial or fungal infection 2.Severe complications 3.MDS, MDS/MPD, MPD 4.Inadequate physical condition, as diagnosed by the primary physician
研究者
相似试验
已完成
1 期
Cancer peptide vaccine therapy for patients with advanced metastatic colorectal cancer. Phase I/II clinical trial.Colorectal cancerJPRN-UMIN000004945Tokai University School of Medicine20
已完成
2 期
WT1 peptide-based cancer vaccine combined with gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a randomised, multicenter, phase 2 clinical studyPancreatic cancerJPRN-UMIN000005248Department of Cancer Immunotherapy, Osaka university Graduate school of Medicine150
招募中
不适用
WT1 peptide-based cancer vaccine for long-term maintenance of anti-tumor immunitysolid tumor, malignant lymphoma, acute leukemiaJPRN-UMIN000015997Osaka University Graduate Shool of Medicine, Functional Diagnostic Science56
招募中
1 期
A clinical study of cancer peptides vaccine therapy using URLC10, CDCA1, and KOC1-targeted peptides in the patients who had no more treatment against oral canceroral cancerJPRN-UMIN000008379Department of Oral and Maxillofacial surgery, Graduated school of medicine Kumamoto University40
招募中
1 期
A clinical study of cancer peptides vaccine therapy in the patients who have recieved surgical resection and had no residual tumor for head and neck cancerhead and neck cancerJPRN-UMIN000008380Department of Oral and Maxillofacial surgery, Graduated school of medicine Kumamoto University50